Special Issue "Transdermal Drug Delivery"

Quicklinks

A special issue of Pharmaceutics (ISSN 1999-4923).

Deadline for manuscript submissions: closed (31 August 2011)

Special Issue Editor

Guest Editor
Prof. Dr. Bozena B. Michniak-Kohn
Pharmaceutics, Ernest Mario School of Pharmacy; Center for Dermal Research (CDR) & Laboratory for Drug Delivery (LDD), NJ Center for Biomaterials, Life Sciences Building, Rutgers-The State University of New Jersey, 145, Bevier Road, Piscataway, NJ 08854, USA
E-Mail: michniak@biology.rutgers.edu
Phone: +1 732 445 3589
Fax: +1 732 445 5006
Interests: topical; transdermal; percutaneous drug delivery; skin transport pathways; skin carrier systems; skin formulations; skin drug delivery; human skin equivalents; skin models

Keywords

  • topical
  • transdermal
  • percutaneous drug delivery
  • skin transport pathways
  • skin carrier systems
  • skin formulations
  • skin drug delivery
  • human skin equivalents
  • skin models

Published Papers (8 papers)

Pharmaceutics 2012, 4(1), 104-129; doi:10.3390/pharmaceutics4010104
Received: 5 December 2011; in revised form: 11 January 2012 / Accepted: 12 January 2012 / Published: 31 January 2012
Show/Hide Abstract | Cited by 9 | PDF Full-text (3218 KB) | HTML Full-text | XML Full-text

Pharmaceutics 2012, 4(1), 71-92; doi:10.3390/pharmaceutics4010071
Received: 14 December 2011; in revised form: 4 January 2012 / Accepted: 4 January 2012 / Published: 17 January 2012
Show/Hide Abstract | PDF Full-text (373 KB) | HTML Full-text | XML Full-text

Pharmaceutics 2012, 4(1), 26-41; doi:10.3390/pharmaceutics4010026
Received: 16 November 2011; in revised form: 15 December 2011 / Accepted: 26 December 2011 / Published: 6 January 2012
Show/Hide Abstract | PDF Full-text (414 KB) | HTML Full-text | XML Full-text

Pharmaceutics 2011, 3(4), 923-931; doi:10.3390/pharmaceutics3040923
Received: 8 October 2011; in revised form: 25 November 2011 / Accepted: 5 December 2011 / Published: 6 December 2011
Show/Hide Abstract | PDF Full-text (199 KB) | HTML Full-text | XML Full-text

Pharmaceutics 2011, 3(4), 914-922; doi:10.3390/pharmaceutics3040914
Received: 8 October 2011; in revised form: 11 November 2011 / Accepted: 14 November 2011 / Published: 21 November 2011
Show/Hide Abstract | PDF Full-text (193 KB) | HTML Full-text | XML Full-text

Pharmaceutics 2011, 3(3), 497-509; doi:10.3390/pharmaceutics3030497
Received: 1 July 2011; in revised form: 4 August 2011 / Accepted: 10 August 2011 / Published: 12 August 2011
Show/Hide Abstract | Cited by 16 | PDF Full-text (1061 KB) | HTML Full-text | XML Full-text

Pharmaceutics 2011, 3(3), 485-496; doi:10.3390/pharmaceutics3030485
Received: 29 June 2011; in revised form: 8 August 2011 / Accepted: 10 August 2011 / Published: 11 August 2011
Show/Hide Abstract | Cited by 1 | PDF Full-text (182 KB) | HTML Full-text | XML Full-text

Pharmaceutics 2011, 3(3), 474-484; doi:10.3390/pharmaceutics3030474
Received: 20 June 2011; in revised form: 3 August 2011 / Accepted: 8 August 2011 / Published: 10 August 2011
Show/Hide Abstract | PDF Full-text (578 KB) | HTML Full-text | XML Full-text

Last update: 4 March 2014

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert